Stephany Michelle Standley

Affiliations: 
2006 University of California, Berkeley, Berkeley, CA, United States 
Google:
"Stephany Standley"
Mean distance: 8.16
 
SNBCP

Parents

Sign in to add mentor
Jean M. J. Fréchet grad student 2006 UC Berkeley
 (Acid -degradable particles for protein -based vaccines.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Iwamoto N, Butler DCD, Svrzikapa N, et al. (2017) Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides. Nature Biotechnology
Wilson SC, Baryza JL, Reynolds AJ, et al. (2015) Real time measurement of PEG shedding from lipid nanoparticles in serum via NMR spectroscopy. Molecular Pharmaceutics. 12: 386-92
Paramonov SE, Bachelder EM, Beaudette TT, et al. (2008) Fully acid-degradable biocompatible polyacetal microparticles for drug delivery. Bioconjugate Chemistry. 19: 911-9
Standley SM, Mende I, Goh SL, et al. (2007) Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. Bioconjugate Chemistry. 18: 77-83
Fréchet J, Jain R, Standley S. (2007) Synthesis of Acid-Degradable Poly(amidoamine)s Synfacts. 2007: 0706-0706
Jain R, Standley SM, Fréchet JMJ. (2007) Synthesis and degradation of pH-sensitive linear poly(amidoamine)s Macromolecules. 40: 452-457
Kwon YJ, Standley SM, Goh SL, et al. (2005) Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 105: 199-212
Kwon YJ, Standley SM, Goodwin AP, et al. (2005) Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses. Molecular Pharmaceutics. 2: 83-91
Standley SM, Kwon YJ, Murthy N, et al. (2004) Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model. Bioconjugate Chemistry. 15: 1281-8
See more...